Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IVCAW
13176
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
| $9.55K | ﹤0.01% |
159,120
| – | – |
2022 Q3
8 quarters
|
|
13177
PUT
PDF Solutions
PDFS
$2.37B
| $9.5K | ﹤0.01% |
300
+200
| +200% | +$6.49K |
2022 Q4
7 quarters
|
|
13178
CALL
Sasol
SSL
$9.01B
| $9.46K | ﹤0.01% |
1,400
+700
| +100% | +$5.19K |
2022 Q4
7 quarters
|
|
|
ZTEK
13179
DELISTED
Zentek
ZTEK
| $9.45K | ﹤0.01% |
13,493
-9,915
| -42% | -$9.15K |
2023 Q2
5 quarters
|
|
13180
PUT
AXT Inc
AXTI
$5.68B
| $9.44K | ﹤0.01% |
3,900
-400
| -9% | -$1.13K |
2022 Q4
7 quarters
|
|
|
ROIC
13181
PUT
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $9.44K | ﹤0.01% |
600
-3,200
| -84% | -$46.8K |
2022 Q4
7 quarters
|
|
13182
PUT
Puma Biotechnology
PBYI
$499M
| $9.44K | ﹤0.01% |
3,700
-14,800
| -80% | -$44.8K |
2022 Q3
8 quarters
|
|
13183
PUT
Verrica Pharmaceuticals
VRCA
$74M
| $9.43K | ﹤0.01% |
650
+20
| +3% | +$901 |
2024 Q2
1 quarter
|
|
|
TUYA
13184
CALL
Tuya Inc
TUYA
$1.03B
| $9.4K | ﹤0.01% |
5,700
+4,100
| +256% | +$6.26K |
2023 Q4
3 quarters
|
|
13185
PUT
iShares US Infrastructure ETF
IFRA
$3.98B
| $9.39K | ﹤0.01% |
200
+100
| +100% | +$4.46K |
2024 Q2
1 quarter
|
|
13186
CALL
OraSure Technologies
OSUR
$283M
| $9.39K | ﹤0.01% |
2,200
-6,300
| -74% | -$27.1K |
2020 Q1
18 quarters
|
|
13187
PUT
NatWest
NWG
$69.3B
| $9.36K | ﹤0.01% |
+1,000
| New | +$8.9K |
2024 Q3
0 quarters
|
|
13188
PUT
Vivani Medical
VANI
$110M
| $9.36K | ﹤0.01% |
8,000
-3,600
| -31% | -$4.5K |
2024 Q1
2 quarters
|
|
|
LDTC
13189
DELISTED
LeddarTech
LDTC
| $9.35K | ﹤0.01% |
+31,705
| New | +$18.5K |
2024 Q3
0 quarters
|
|
|
CYTO
13190
DELISTED
Altamira Therapeutics Ltd
CYTO
| $9.35K | ﹤0.01% |
+14,802
| New | +$14.7K |
2024 Q3
0 quarters
|
|
|
KRON
13191
CALL
DELISTED
Kronos Bio
KRON
| $9.3K | ﹤0.01% |
9,300
-22,100
| -70% | -$24.5K |
2024 Q1
2 quarters
|
|
13192
CLPS Inc
CLPS
$30.4M
| $9.28K | ﹤0.01% |
6,584
-13,685
| -68% | -$14K |
2022 Q2
9 quarters
|
|
|
AHT
13193
CALL
Ashford Hospitality Trust
AHT
$14.6M
| $9.28K | ﹤0.01% |
1,240
-350
| -22% | -$3.28K |
2024 Q2
1 quarter
|
|
13194
CALL
Amtech Systems
ASYS
$312M
| $9.28K | ﹤0.01% |
1,600
+500
| +45% | +$3.04K |
2022 Q4
7 quarters
|
|
|
LX
13195
CALL
LexinFintech Holdings
LX
$111M
| $9.25K | ﹤0.01% |
3,400
+3,100
| +1,033% | +$5.41K |
2020 Q4
15 quarters
|
|
13196
ARB IOT Group
ARBB
$7.91M
| $9.22K | ﹤0.01% |
2,206
-6,721
| -75% | -$37.6K |
2024 Q2
1 quarter
|
|
13197
CALL
Alerus Financial
ALRS
$808M
| $9.15K | ﹤0.01% |
+400
| New | +$8.54K |
2024 Q3
0 quarters
|
|
|
PWSC
13198
PUT
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $9.12K | ﹤0.01% |
400
-500
| -56% | -$11.3K |
2023 Q1
6 quarters
|
|
13199
CALL
KULR Technology Group
KULR
$118M
| $9.12K | ﹤0.01% |
4,000
-15,900
| -80% | -$35.7K |
2024 Q1
2 quarters
|
|
13200
CALL
Neuropace
NPCE
$454M
| $9.06K | ﹤0.01% |
1,300
-7,100
| -85% | -$51.9K |
2024 Q1
2 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.